The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome (Q42512915)

1 November 2017

The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome (English)

1 reference

1 November 2017

S J Muasher

1

1 reference

1 November 2017

S Oehninger

2

1 reference

1 November 2017

S Simonetti

3

1 reference

1 November 2017

J Matta

4

1 reference

1 November 2017

L M Ellis

5

1 reference

1 November 2017

H C Liu

6

1 reference

1 November 2017

G S Jones

7

1 reference

1 November 2017

Z Rosenwaks

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 August 1988

1 reference

1 November 2017

Fertility and Sterility

1 reference

1 November 2017

50

1 reference

1 November 2017

2

1 reference

1 November 2017

298-307

1 reference

Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

The importance of the follicular phase to success and failure in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Stimulation protocols for patients with "atypical response".

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

The perimenopausal patient in in vitro fertilization: the use of gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Three years of in vitro fertilization at Norfolk.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Sex hormone levels and gonadotrophin release in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Outcome of in vitro fertilization in women with low response to ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2960077-8

7 January 2021

10.1016/S0015-0282(16)60077-8

Identifiers

DOI

0 references

1 reference